Skip to main navigation Skip to search Skip to main content

Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)451-465
Number of pages15
JournalJournal of Biological Inorganic Chemistry
Volume25
Issue number3
DOIs
Publication statusPublished - May 2020

Funding

Open access funding provided by University of Vienna. The authors would like to thank the Johanna Mahlke nee Obermann Foundation for financial support within the project "Exploring Novel Protein Targets of Anticancer Metal Compounds". JJN acknowledges funding from Comunidad de Madrid through the Attraction of Talent Program 2018, Grant Ref. 2018-T1/BMD-10261. The Vienna Scientific Cluster is acknowledged for generous computational support.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 104003 Inorganic chemistry
  • 104004 Chemical biology
  • 301904 Cancer research

Keywords

  • Topoisomerase II alpha
  • Metal complex
  • Anticancer drug
  • Molecular dynamics
  • Monte Carlo simulation
  • RNA interference
  • PROTEIN SIDE-CHAIN
  • H2AX PHOSPHORYLATION
  • CELL-CYCLE
  • DNA
  • CANCER
  • CHEMOSENSITIVITY
  • PARAMETERS
  • RESISTANCE
  • EXPRESSION
  • DIVISION
  • Topoisomerase IIα

Fingerprint

Dive into the research topics of 'Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors'. Together they form a unique fingerprint.

Cite this